Educational Website for Colorectal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial evaluates an online educational tool called Current Together after Cancer (CTAC) to determine if it can help individuals who have undergone stage II or III colorectal cancer surgery adhere more effectively to their surveillance care plans. Proper surveillance care is crucial for early detection of cancer recurrence, yet many survivors miss it due to lack of information or confidence. The trial uses a website to enhance understanding and encourage communication with a supportive person, such as a family member or friend. Individuals who recently had stage II or III colorectal cancer surgery and have a supportive person in their cancer journey may be suitable for this trial. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the opportunity to contribute to a potentially groundbreaking tool for cancer care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on an educational website rather than medication changes.
What prior data suggests that this web-based intervention is safe?
Research has shown that the Current Together after Cancer (CTAC) program is an online educational tool designed to improve follow-up care for colorectal cancer survivors. As the program is in a phase III study, it has already passed earlier stages focused on safety. These earlier trials ensured that the program is safe and generally well-tolerated.
Being an online platform, the CTAC program does not cause physical side effects like those from drugs or medical procedures. It aims to educate and empower patients with information, which is typically considered safe. Participants use the website to learn more about their care and how to manage it. So far, other studies have not reported negative effects from using this type of educational tool.
The goal is to enhance knowledge and confidence in managing health, suggesting a low risk for negative outcomes. This makes the CTAC program a safe option for those seeking to better understand their post-cancer care.12345Why are researchers excited about this trial?
Researchers are excited about the Current Together after Cancer (CTAC) intervention because it offers a fresh approach to supporting colorectal cancer patients and their supporters. Unlike current treatments that focus primarily on medical and surgical interventions, CTAC provides a comprehensive online educational platform. This website empowers users with easily accessible information about managing life after cancer, fostering a sense of control and community. By enhancing understanding and support, CTAC aims to improve the overall well-being and quality of life for everyone involved.
What evidence suggests that the CTAC intervention is effective for increasing guideline-concordant surveillance care in colorectal cancer patients?
Studies have shown that up to 60% of colorectal cancer survivors do not receive the recommended follow-up care after surgery. This gap may result from a lack of understanding about the importance of follow-up or uncertainty about managing their care. In this trial, participants in Group 1 will access the Current Together after Cancer (CTAC) program, an online tool designed to address these issues. The program aims to improve patients' knowledge and confidence in managing their follow-up care. Early results suggest that increased understanding and confidence can lead to more patients receiving appropriate follow-up care. This could help detect any cancer recurrence earlier, when it is easier to treat.12346
Who Is on the Research Team?
Christine M Veenstra
Principal Investigator
SWOG Cancer Research Network
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had stage II or III colorectal cancer surgically removed and are within 90-180 days post-surgery. They should be in fair health (Zubrod status of 0-2) and have a supportive adult willing to engage with an educational website, though the supporter's participation isn't mandatory.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive access to the CTAC intervention or control website and may review the content as frequently as they like
Follow-up
Participants are monitored for knowledge, self-efficacy, and satisfaction with supporter engagement at 3 and 16 months
What Are the Treatments Tested in This Trial?
Interventions
- Current Together after Cancer (CTAC)
Trial Overview
The study tests if an online education platform called Current Together after Cancer (CTAC) can improve follow-up care for colorectal cancer survivors by increasing their knowledge, self-efficacy, and communication with supporters.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Patients and supporter participants receive access to the CTAC intervention website and may review the content as frequently as they like for up to 16 months on study.
Patients and supporter participants receive access to a general health education website and may review the content as frequently as they like for up to 16 months on study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
SWOG Cancer Research Network
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Citations
Study Details | NCT07018869 | Evaluating Whether an ...
This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with ...
Evaluating Whether an Educational Website called Current ...
This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with ...
Evaluating Whether an Educational Website Called ...
This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of ...
Improving Uptake of Surveillance in Colorectal Cancer ...
This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer ...
Clinical Trials
A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention called Current Together After Cancer (CTAC) to Promote Guideline- ...
Updated patient reported outcomes and survivorship care ...
Overall, 63% reported chronic changes in bowel patterns, 38% chronic diarrhea, 9% bowel obstruction, 18% hernia development, 8% radiation colitis, and 2% ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.